je.st
news
Tag: positive
Corning Given Positive Rating at Susquehanna
2015-09-26 08:43:09| Electronics - Topix.net
's stock had its "positive" rating reaffirmed by investment analysts at Susquehanna in a research report issued on Friday, MarketBeat reports. They currently have a $22.00 price target on the glassware maker's stock, down from their previous price target of $27.00.
Tags: rating
positive
corning
susquehanna
Corning Given Positive Rating at Susquehanna
2015-09-26 08:13:36| Chemicals - Topix.net
's stock had its "positive" rating reaffirmed by investment analysts at Susquehanna in a research report issued on Friday, MarketBeat reports. They currently have a $22.00 price target on the glassware maker's stock, down from their previous price target of $27.00.
Tags: rating
positive
corning
susquehanna
Biogen and Sobi Receive Positive Opinion from CHMP for ELOCTAa ...
2015-09-26 06:58:18| Appliances - Topix.net
CAMBRIDGE, Mass. & STOCKHOLM -- -- Biogen and Swedish Orphan Biovitrum AB received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use for the marketing authorization of ELOCTA .
Tags: receive
positive
opinion
biogen
Premarket Biotech Digest: Arrowhead's Positive Results, Keryx's...
2015-09-25 18:09:27| Biotech - Topix.net
The CHMP is EU's review body, something like the FDA's Advisory Committee, but one that the EMA listens to more closely than does the FDA to its AdComm. The CHMP has recommended Entresto, the heart failure drug of Novartis , for approval in the EU.
Tags: results
positive
digest
biotech
Celgene's VIDAZA (Azacitidine for Injection) Receives Positive CHMP...
2015-09-25 15:59:38| Biotech - Topix.net
Expanded indication brings medicine to elderly AML patients who are not eligible for haematopoietic stem cell transplantation and who have >30% myeloblasts in their bone marrow BOUDRY, Switzerland-- -- Celgene International SA rl, a wholly owned subsidiary of Celgene Corporation today announced that that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for an expanded indication of VIDAZAA for the treatment of adult patients aged 65 years or older with acute myeloid leukaemia who are not eligible for haematopoietic stem cell transplantation .
Tags: positive
receives
injection
chmp
Sites : [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] next »